A comparison between BC 105 and methysergide in the prophylaxis of migraine.
D000293:Adolescent; D000328:Adult; D001835:Body Weight; D002986:Clinical Trials as Topic; D003508:Cycloheptanes / Q000009:adverse effects / Q000627:therapeutic use; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D006261:Headache / Q000517:prevention & control; D006801:Humans; D008297:Male; D008784:Methysergide / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D008881:Migraine Disorders / Q000517:prevention & control*; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D003508:Cycloheptanes; D010880:Piperidines; D013876:Thiophenes; D008784:Methysergide